• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antithrombin III activity and concentration in diabetes mellitus.

作者信息

Patrassi G M, Picchinenna R, Vettor R, Cappellato G, Coccarielli D, Girolami A

出版信息

Thromb Haemost. 1985 Aug 30;54(2):415-7.

PMID:3936213
Abstract

Antithrombin III (AT III) levels have been reported to be low, normal, and high in diabetes mellitus. Furthermore, a discrepancy between AT III activity and antigen concentration was reported. We have evaluated the behaviour of AT III activity and antigen level both in type 1 and type 2 diabetes, either in uncontrolled or in well controlled patients. AT III activity and antigen levels showed values similar to normal. No difference was seen between type 1 and type 2 diabetes. Similar results were observed in the group of well controlled diabetic patients. AT III activity and antigen did not correlate with blood glucose and glycosylated haemoglobin (HbA1). No difference was observed between AT III activity and antigen levels in any group. Therefore the hypercoagulable state found in diabetes mellitus does not depend on AT III modifications. A discrepancy between AT III activity and antigen was not confirmed. A dysantithrombinaemia, explained on the basis of an inactivation of protein glycosylation in diabetes mellitus has not been confirmed.

摘要

相似文献

1
Antithrombin III activity and concentration in diabetes mellitus.
Thromb Haemost. 1985 Aug 30;54(2):415-7.
2
Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report.糖尿病患者抗凝血酶III活性降低可能与非酶糖基化有关——初步报告。
Thromb Haemost. 1983 Oct 31;50(3):633-4.
3
Functional activities and nonenzymatic glycosylation of plasma proteinase inhibitors in diabetes.糖尿病患者血浆蛋白酶抑制剂的功能活性与非酶糖基化作用
Clin Chim Acta. 1986 Oct 15;160(1):55-62. doi: 10.1016/0009-8981(86)90335-9.
4
Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.在胰岛素依赖型糖尿病中,每日快速的血糖变化可能会影响抗凝血酶III的生物活性,但不会影响其血浆浓度。不稳定的非酶糖基化可能起到一定作用。
Diabete Metab. 1987 Feb;13(1):16-9.
5
Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation.代谢控制可能改变抗凝血酶III的活性,但不会改变糖尿病患者血浆中其浓度:非酶糖基化可能起作用。
Diabetes Care. 1986 Jan-Feb;9(1):32-5. doi: 10.2337/diacare.9.1.32.
6
Glycosylated haemoglobin and blood glucose levels in Libyan diabetic patients.利比亚糖尿病患者的糖化血红蛋白和血糖水平
Trop Geogr Med. 1986 Dec;38(4):391-7.
7
[Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus].[糖尿病患者血糖、糖化血红蛋白及糖化血清蛋白值的动态变化]
Vutr Boles. 1987;26(6):107-10.
8
Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.胰岛素依赖型糖尿病患者的凝血与纤溶系统损害
Thromb Res. 1992 Sep 15;67(6):643-54. doi: 10.1016/0049-3848(92)90068-l.
9
Effect of insulin therapy on coagulation and platelet function in type II (non-insulin-dependent) diabetes mellitus.胰岛素治疗对II型(非胰岛素依赖型)糖尿病患者凝血及血小板功能的影响。
Haemostasis. 1986;16(6):417-23. doi: 10.1159/000215318.
10
[Behavior of glycosylated hemoglobin (HbA1) and fasting blood glucose in normal subjects and in patients with diabetes mellitus].[正常人和糖尿病患者糖化血红蛋白(HbA1)及空腹血糖的变化]
AMB Rev Assoc Med Bras. 1985 Nov-Dec;31(11-12):227-31.

引用本文的文献

1
Physiological inhibitors of blood coagulation and prothrombin fragment F 1 + 2 in type 2 diabetic patients with normoalbuminuria and incipient nephropathy.正常白蛋白尿和早期肾病的2型糖尿病患者的生理性凝血抑制剂及凝血酶原片段F1+2
Acta Diabetol. 1996 Sep;33(3):241-5. doi: 10.1007/BF02048551.